- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.16: 2 residues within 4Å:- Chain A: Y.18, N.51
Ligand excluded by PLIPNAG.17: 4 residues within 4Å:- Chain A: N.112, T.114, V.117, F.147
Ligand excluded by PLIPNAG.18: 5 residues within 4Å:- Chain A: Q.105, E.122, N.155, T.157
- Chain C: R.347
Ligand excluded by PLIPNAG.19: 1 residues within 4Å:- Chain A: N.224
Ligand excluded by PLIPNAG.20: 2 residues within 4Å:- Chain A: E.271, N.272
Ligand excluded by PLIPNAG.21: 4 residues within 4Å:- Chain A: N.321, P.569, Q.570, T.571
Ligand excluded by PLIPNAG.22: 1 residues within 4Å:- Chain A: N.606
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain A: N.647
Ligand excluded by PLIPNAG.24: 1 residues within 4Å:- Chain A: N.699
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain A: A.696, E.1062, N.1064
Ligand excluded by PLIPNAG.26: 1 residues within 4Å:- Chain B: N.51
Ligand excluded by PLIPNAG.27: 5 residues within 4Å:- Chain B: V.110, N.112, T.114, V.117, F.147
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain B: E.122, N.155, T.157
Ligand excluded by PLIPNAG.29: 1 residues within 4Å:- Chain B: N.224
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain B: E.271, N.272
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain B: N.321, I.322, Q.570
Ligand excluded by PLIPNAG.32: 1 residues within 4Å:- Chain B: N.606
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain B: N.647
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain B: N.699
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain B: A.696, E.1062, N.1064
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain C: N.51
Ligand excluded by PLIPNAG.37: 5 residues within 4Å:- Chain C: V.110, N.112, T.114, V.117, F.147
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain C: E.122, N.155
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain C: N.224
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain B: K.548
- Chain C: E.271, N.272
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain C: N.321, Q.570
Ligand excluded by PLIPNAG.42: 1 residues within 4Å:- Chain C: N.606
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain C: H.645, N.647
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain A: D.786
- Chain C: N.699
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain C: N.1064
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yan, Q. et al., Antibodies utilizing VL6-57 light chains target a convergent cryptic epitope on SARS-CoV-2 spike protein and potentially drive the genesis of Omicron variants. Nat Commun (2024)
- Release Date
- 2024-08-21
- Peptides
- Spike glycoprotein,Fibritin,Expression Tag: ABC
Heavy chain of R1-26 Fab: DFH
Light chain of R1-26 Fab: EGI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HF
FH
JE
LG
GI
K
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yan, Q. et al., Antibodies utilizing VL6-57 light chains target a convergent cryptic epitope on SARS-CoV-2 spike protein and potentially drive the genesis of Omicron variants. Nat Commun (2024)
- Release Date
- 2024-08-21
- Peptides
- Spike glycoprotein,Fibritin,Expression Tag: ABC
Heavy chain of R1-26 Fab: DFH
Light chain of R1-26 Fab: EGI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HF
FH
JE
LG
GI
K